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Gene regulationAbstract Autism spectrum disorder (ASD) refers to a group of childhood neurodevelopmental dis-
orderswith polygenic etiology. The expressionofmany genes implicated inASD is tightly regulated by
various factors including microRNAs (miRNAs), a class of noncoding RNAs 22 nucleotides in
length that function to suppress translation by pairing with ‘miRNA recognition elements’ (MREs)
present in the 30untranslated region (30UTR) of target mRNAs. This emphasizes the role played by
miRNAs in regulating neurogenesis, brain development and differentiation and hence any perturba-
tions in this regulatory mechanism might affect these processes as well. Recently, single nucleotide
polymorphisms (SNPs) present within 30UTRs of mRNAs have been shown to modulate existing
MREs or even create new MREs. Therefore, we hypothesized that SNPs perturbing miRNA-medi-
ated gene regulation might lead to aberrant expression of autism-implicated genes, thus resulting in
disease predisposition or pathogenesis in at least a subpopulation of ASD individuals. We developed
a systematic computational pipeline that integrates data fromwell-establisheddatabases. By following
a stringent selection criterion, we identiﬁed 9 MRE-modulating SNPs and another 12 MRE-creating
SNPs in the 30UTRof autism-implicated genes. These high-conﬁdence candidate SNPsmay play roles
in ASD and hence would be valuable for further functional validation.Introduction
Autism spectrum disorder (ASD) represents a series of neuro-
developmental disorders characterized by altered social inter-
ests, communicative deﬁcits, and restricted and repetitive
behaviors, usually with an onset before the age of three [1].
Although ASD is deﬁned by a triad of symptoms, the levels
of severity and presentation may vary among individuals,
demonstrating the tremendous heterogeneity of the condition.hosting
Vaishnavi V et al / MicroRNA Binding Site Polymorphisms in Autism 93The burden of ASD is increasing worldwide with recent prev-
alence estimates of 62 per 10,000 children [2]. Research in the
last several years has substantiated the strong genetic basis and
has further established the polygenic etiology of ASD [3,4].
For instance, a comprehensive transcriptomic analysis was
performed to measure mRNA levels in post-mortem brains
from autistic individuals and controls using Illumina micro-
arrays. As a result, 444 genes were found to be differentially
expressed [5]. This disease-speciﬁc, aberrant expression of
genes may be caused by various factors, such as the presence
of submicroscopic structural chromosomal alterations in the
genome denoted as copy number variants (CNVs), or by per-
turbations in many regulatory mechanisms that govern gene
expression [6–8]. Very recently, methylomic analysis of
monozygotic twins discordant for ASD identiﬁed epigenetic
variations that mediate disease susceptibility via altered gene
dosage [9]. Besides gene dysfunction, studies reveal that the
known etiological factors of ASD eventually converge toward
the unifying theme of aberrant gene expression [5–9].
MicroRNAs (miRNAs) have emerged as key regulators for
nearly 50% of protein-coding genes in the human genome,
participating in all vital cellular processes [10–12]. miRNAs
represent a class of short (22 nt) endogenous noncoding
RNAs that pairs with complementary sequences called miR-
NA recognition elements (MREs), which are located mostly
in the 30untranslated region (30UTR) of target mRNAs. This
miRNA:MRE pairing leads to translational inhibition or
mRNA destabilization by recruiting the RNA-induced silenc-
ing complex (RISC). In mammals, complete complementarity
between miRNA and MRE is rare, since a minimal 6-bp match
of nucleotides 2–8 at the 50 end of miRNA (known as the seed
region) is sufﬁcient for functionality [13]. Thus a single miR-
NA can target approximately 200 transcripts, and more than
one miRNA can act upon a single mRNA target [14]. Impor-
tantly, almost 70% of experimentally-detectable miRNAs are
expressed in the human nervous system [15]. Several miRNAs
orchestrate a myriad of diverse neurodevelopmental processes
including neuronal cell speciﬁcation and differentiation, synap-
tic plasticity and memory formation [16]. Accumulating evi-
dence suggests that alterations in miRNA expression or
function are associated with the cognitive deﬁcits and neurode-
velopmental abnormalities observed in autism, schizophrenia
and other forms of intellectual dysfunction [17–20]. According
to a recent bioinformatics study, co-expression of neural miR-
NAs with their target mRNAs is a common feature [21], sug-
gesting that any interference in miRNA:MRE interactions
might affect the physiological control of gene expression.
Additionally, single nucleotide polymorphisms (SNPs) in the
30UTR of genes are recognized for their ability to perturb miR-
NA binding by modulating existing MREs or by creating new
MREs [22–25]. The pathological signiﬁcance of this unique
class of functional polymorphisms is gaining recognition and
their biological relevance has been explored in various diseases
[26,27], including neurodegenerative diseases [28,29]. To our
knowledge, MRE-SNPs have not formed the basis of any pre-
vious case-control studies in autism, and their systematic
assessment might extend our understanding of the complex
genetic architecture of this highly heterogeneous disorder.
However, the identiﬁcation of ASD-associated MRE-SNPs
poses a considerable challenge due to the lack of an established
model that accounts for the heterogeneity of ASD and the
ever-expanding modes of miRNA-mediated gene regulation.At this point, computational approaches are still the driving
force in identifying truly functional genetic variants within
MREs, and numerous databases have been developed to assist
in this process. Aided by a rigorous bioinformatics approach,
we identiﬁed a panel of high-conﬁdence SNPs that either mod-
ulate existing MREs or create new MREs in the 30UTR of aut-
ism-implicated genes. We propose that alterations in the
miRNA:MRE interaction caused by these MRE-SNPs could
be an alternate mechanism underlying aberrant gene expres-
sion, which may contribute to predisposition, pathogenesis,
inter-individual variation in gene expression, and heterogene-
ity of ASD (Figure 1). Future experimental validations may
further clarify the effect and consequences of these candidate
SNPs.Results
Study design and preliminary analyses
We followed a stepwise, integrative and stringent computa-
tional pipeline to identify and characterize MRE-SNPs in the
30UTR of autism-implicated genes (Figure 2). A total of 484
genes were retrieved from the ‘‘Human Gene Module’’ of
‘SFARI Gene’, a comprehensive resource for obtaining reli-
able data on the genetics of ASD [30]. SNPs that modulate
or create MREs across the 30UTR of these genes were identi-
ﬁed using MirSNP database [31]. The resultant list contained
13,945 SNPs in 468 out of the 484 autism-implicated genes.
We chose MirSNP due to its high sensitivity in covering a
majority of the validated miRNA-related SNPs when com-
pared to other databases [31]. MirSNP also provides informa-
tion on the plausible effect of SNPs on miRNA binding and
categorizes them into one of the four functional classes. These
include (i) break –– SNP completely disrupts the binding of
miRNA to the MRE, (ii) decrease –– SNP reduces the binding
efﬁcacy of the miRNA to the MRE, (iii) enhance –– SNP
increases the binding afﬁnity of the miRNA to the MRE and
(iv) create –– SNP creates new MREs for miRNAs. We
grouped the ﬁrst three functional classes as MRE modulating
SNPs (MREm-SNPs) since the existing miRNA recognition
sites were modiﬁed. The fourth category that created new
MREs (MREc-SNPs) was considered as a separate group.
Next, we checked the minor allele frequencies (MAFs) of these
SNPs in Exome Variant Server (EVS) maintained by the
National Heart, Lung and Blood Institute (NHLBI) Exome
Sequencing Project. The EVS was chosen for several reasons.
First, the database serves as a large repository for more than
10 million human SNPs identiﬁed by sequencing 15,336 genes
in 6515 individuals of European American (EA) and African
American (AA) ancestry [32]. Second, even SNPs with MAF
as low as 0.1% can be identiﬁed owing to the larger sample
size. Third, EVS also indicates the level of conservation and
evolutionary constraints of the SNP loci by providing phyloge-
netic analysis with space/time model for conservation (phast-
Cons) and genomic evolutionary rate proﬁling (GERP)
scores. Finally, for many SNPs, the MAF is unavailable in
NCBI’s dbSNP. Of the 13,945 SNPs we identiﬁed, it was inter-
esting to note that only 387 spanning the 30UTR of 181 autism-
implicated genes were documented with a MAF> 0.1% in at
least one population (EA or AA). This suggests that the vast
majority of MRE-SNPs are either very rare or not detected
3′
Figure 1 SNPs in MREs of autism-implicated genes may underlie ASD etiology
SNPs in the 30UTR of autism-implicated genes may either modulate existing MREs or create new MREs thereby leading to aberrant
expression of these genes, which may underlie predisposition, pathogenesis or genetic heterogeneity of autism. The ‘‘DNA–brain’’ image is
adopted from the public domain http://neurosciencenews.com/ﬁles/2013/06/dna-brain-familial-alziheimers-public.jpg, which is credited to
the National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH) and is appropriately modiﬁed.
MRE, miRNA recognition element.
94 Genomics Proteomics Bioinformatics 12 (2014) 92–104in samples of the speciﬁed ancestry. Alternatively, it may indi-
cate the action of purifying selection on MRE-SNPs [33].
Minimizing false positive MREs
The ﬁrst step in the identiﬁcation of MREm-SNPs relies on the
correct prediction of functional MREs in the 30UTR of aut-
ism-implicated genes. MirSNP database employs the miRanda
miRNA target prediction algorithm [34]. Despite the high sen-
sitivity of miRanda [35], the reliability of a single prediction
method is modest. To account for this, the MREs were sub-
jected to consistent cross-prediction by TargetScanHuman
6.2 [36,37] and RNAhybrid 2.1 [38,39]. Furthermore, we
improved the stringency of the prediction by considering cer-
tain quantitative scores. As an added feature, the MirSNP
database provides an miRSVR score, which was developed
by supervised training on mRNA expression data from a panel
of miRNA transfection experiments [40]. We considered only
the top miRSVR predictions with a score of <0.1, which
have greater probability for down regulating the target
mRNAs. However, MirSNP does not provide an miRSVR
score for all predicted MREs. Therefore, additional care was
taken to minimize the exclusion of true positives that lack an
miRSVR score by considering the ‘total context score’ given
by TargetScan, which effectively ranks the predicted MREs
based on their local and global contextual features [37].
Obtaining high-conﬁdence and tissue-speciﬁc datasets
The miRNA–MRE interaction involves base pairing that
requires favorable hybridization energy for the formation ofa functional duplex. We computed the free energy of binding
of the miRNA:MRE duplex by analyzing their sequences in
RNAhybrid. A maximum hybridization energy of 15 kcal/
mol was used as the scoring criteria to select stable duplexes.
All of these sequential ﬁltering steps aided the identiﬁcation
of high-conﬁdence functional MREs and thus, MREm-SNPs.
However, the biological relevance of these SNPs depends on
whether the miRNA and its target mRNAs are co-expressed
in a particular tissue or cell type. Considering the neurobio-
logical basis of ASD, we shortlisted only those MREs that
served as binding sites for the brain expressed human miR-
NAs. This brain-speciﬁc miRNA dataset consisted of overlap-
ping miRNAs from two independent studies that proﬁled the
expression of miRNAs in different regions of post-mortem
human brain tissue samples [41,42]. In total, 9 MREm-SNPs
were identiﬁed across the 30UTR of 17 transcripts (Table 1).
The effect on miRNA binding was veriﬁed by computing the
difference in hybridization energy (DDG) caused by that par-
ticular SNP (see Materials and methods section). The greater
the DDG value is, the greater the impact of the SNP will be.
The presence of the variant allele for the MREm-SNPs
rs56124628 in CSNK1D encoding casein kinase 1 delta,
rs28390202 in PLCB1 encoding phospholipase C beta 1,
rs148637931 in PRKCB encoding protein kinase C beta,
rs114517919 in SLC16A3 encoding solute carrier family 16
member 3, and rs1042589 in TPO (thyroid peroxidase)
decreases the binding efﬁciency of their corresponding miR-
NAs (indicated by their lower negative DDG value) to the
respective mRNA transcripts and may therefore allow ‘‘leaky’’
translation. On the other hand, the SNPs rs112904440 in
SNRPN encoding small nuclear ribonucleoprotein polypeptide
′Figure 2 Work ﬂow to identify high-conﬁdence SNPs that modulate existing MREs or create new MREs
Vaishnavi V et al / MicroRNA Binding Site Polymorphisms in Autism 95N, rs28915687 in TPO and rs113141381 in YEATS2 encoding
YEATS domain-containing 2 may lead to over expression of
the respective mRNA transcripts by completely disrupting
the MRE so that the miRNA cannot bind (indicated
by the higher negative DDG value). Only one SNP, namely
rs28562651 in NTRK3 encoding neurotrophic tyrosine kinase
receptor type 3, was found to enhance the binding efﬁciency
of hsa-miR-489 to its MRE (indicated by the positive DDG
value) thus ‘‘over’’ repressing the translation of NTRK3.
Graphical illustrations of each category of MREm-SNPs are
provided in Figure 3 (AC).SNPs in 30UTR creates new MREs
While concordant cross-prediction of existing MREs and
the corresponding binding miRNAs is straight forward, thechallenge is to predict those MREs that are created exclusively
by the presence of variant alleles at the SNP loci. We followed
a logical framework to reﬁne the MREc-SNPs identiﬁed with
a MAF> 0.1%. First, the SNP involved 30UTR sequence
should not serve as an MRE for any miRNA when the ances-
tral allele is present, and this was cross veriﬁed by (i) the miR-
anda algorithm embedded within MirSNP, (ii) TargetScan and
(iii) RNAhybrid. Second, the introduction of variant alleles at
the SNP loci should create a perfect seed match for miRNA(s)
and confer favorable hybridization energy for the formation of
miRNA:MRE duplex. This was accounted for by analyzing
the sequence of each created MRE and its corresponding miR-
NA for canonical hybridization features in RNAhybrid. The
results were manually inspected, and only the MREs that were
created for miRNAs expressed in the human brain were
considered. A total of 12 SNPs were found to create 35 new
MREs across the 30UTR of 29 transcripts with favorable
Table 1 High-conﬁdence MREm-SNPs in the 30UTR of autism-implicated genes
Gene symbol Transcript ID MREm-SNP ID Allele change Putative miRNA aﬀected miRSVR/total context score miRNA binding G (kcal/mol) GERP phastCons
CSNK1D NM_139062 rs56124628 GﬁC miR-671-5p 0.692/0.1 ﬂ 1.1 3.37 1.0
NTRK3 NM_001007156 rs28562651 TﬁG miR-489 0.422/0.17 › 4.1 2.68 1.0
PLCB1 NM_182734 rs28390202 CﬁT miR-423-5p 0.379/0.4 ﬂ 2 0.69 0.991
PRKCB NM_002738 rs148637931 CﬁT miR-194-3p 0.225/0.02 ﬂ 2.2 3.65 0.034
SLC16A3 NM_004207 rs114517919 CﬁT miR-550a-5p 0.208/0.27 ﬂ 1.7 1.26 1.0
SNRPN NM_003097
NM_022805
NM_022806
NM_022807
NM_022808
rs112904440 CﬁG/T miR-134 0.734/0.27 X 18.8 3.27 0
TPO NM_000547
NM_001206744
rs1042589 CﬁG miR-370 1.017/0.44 ﬂ 3.7 0.71 0
NM_001206745
NM_175719
NM_175721
NM_175722
rs28915687 AﬁT miR-127-5p 1.017/0.15 X 18.2 1.38 0
YEATS2 NM_018023 rs113141381 CﬁT miR-935 0.122/0.29 X 27.3 1.55 0
Note:MREm-SNP stands for MRE-modulating SNP; decrease and increase in miRNA binding are indicated with ﬂ and ›, respectively, while X indicates complete disruption of miRNA binding. DDG
indicates difference in minimum free energy. GERP, genomic evolutionary rate proﬁling; phastCons, phylogenetic analysis with space/time model for conservation; CSNK1D, casein kinase 1, delta;
NTRK3, neurotrophic tyrosine kinase, receptor type 3; PLCB1, phospholipase C beta 1; SLC16A3, solute carrier family 16 member 3; SNRPN, small nuclear ribonucleoprotein polypeptide N;
TPO, thyroid peroxidase; YEATS2, YEATS domain-containing 2.
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Figure 3 Modulation of existing MREs and creation of new MREs by 30UTR SNPs in autism-implicated genes
The position of SNP within the 30UTR is indicated by arrow marks. The minimum free energy (MFE) of the miRNA:MRE duplex is
enclosed within rectangular boxes. A. The variant allele ‘G’ of rs1042589 decreases the MFE and the binding efﬁciency of hsa-miR-370 to
TPO. B. The variant allele of rs28562651 increases the MFE and binding efﬁciency of hsa-miR-489 to the 30UTR of NTRK3. C. Shown is
the complementary base pairing between hsa-miR-134 and its MRE in the 30UTR of SNRPN. The presence of the variant allele ‘G’
completely abrogates the seed paring. D. The variant allele ‘G’ of rs11122391 in the 30UTR of DISC1 creates a perfect match for the seed
region of hsa-miR-137. However, in the presence of the ancestral allele ‘A’, hsa-miR-137 cannot bind the 30UTR of DISC1. TPO, thyroid
peroxidase; NTRK3, neurotrophic tyrosine kinase receptor type 3; SNRPN, small nuclear ribonucleoprotein polypeptide N; DISC1,
disrupted in schizophrenia 1.
Vaishnavi V et al / MicroRNA Binding Site Polymorphisms in Autism 97hybridization energy for 14 different miRNAs (Table 2). These
MREc-SNPs may lead to down regulation in the expression of
their corresponding genes by providing illegitimate MREs for
additional new miRNAs. Of these, rs7701616 created an MRE
for hsa-miR-369-3p across 17 transcripts of the PCDHA gene
cluster encoding protocadherin alpha. Of note, the SNP
rs140716866 in the 30UTR of PIK3CG encoding phosphot-
idylinositol-4, 5-bisphosphate 3-kinase, catalytic subunit
gamma created a new MRE to which three neuronal miRNAs,
hsa-miR-140-3p, hsa-miR-589-3p and hsa-miR-497-3p, can
bind, while rs138867267 in the 30UTR of SCFD2 encoding
sec 1 family domain-containing 2 created a new MRE for
hsa-miR-33a-5p and hsa-miR-33b-5p. The remaining SNPs
created a MRE for one miRNA each and a graphical represen-
tation of an example is given in Figure 3D.
Aberrant gene expression and associated mouse phenotypes
As described before, we selected only the genes implicated in
autism and miRNAs expressed in the human brain. Therefore,
interference in miRNA regulation caused by MRE-SNPs may
lead to neuro-pathological effects ranging from low to veryhigh. To better understand the consequences of altered gene
expression induced by the MRE-SNPs, we compiled data on
the phenotypes produced in mice when the gene homologs
were knocked out or targeted. The mouse phenotype data were
retrieved from Mouse Genome Informatics (MGI) database
[43]. Mice with homozygous null or targeted genes, such as
Ntrk3, Plcb1, Prkcb, Disc1, Ephb2 and Rgs7, were shown to
exhibit deﬁcits or changes in various neurobiological activities
(Table 3). Mouse defective for three of these genes were asso-
ciated with human disease models. These genes include Plcb1
for Alzheimer’s disease and schizophrenia, Snrpn for Angel-
man Syndrome and Prader-Willi Syndrome, and Disc1 for
schizophrenia and major depressive disorder. On the other
hand, the phenotypes of mice defective for Csnk1d, Slc16a3,
Tpo, Yeats2, Ephb2, Hepacam, H2-Eb1 (homolog for HLA-
DRB1), Pcdha1, Pik3cg, Scfd2, Tnip2 and Xirp1 were not asso-
ciated with any observable neurobiological deﬁcits (Table S1).
However, these genes are associated with the etiology of ASD
in humans. Altogether, our results provide in silico evidence
for the potential of MRE-SNPs to induce aberrant expression
of ASD implicated genes in the human brain that might lead
to neurobiological dysfunction and cognitive deﬁcits. The
Table 2 High-conﬁdence MREc-SNPs in the 30UTR of autism-implicated genes
Gene symbol Transcript ID MREc-SNP ID Allele change miRNA with MRE created G (kcal/mol) GERP phastCons
DISC1 NM_001164541 rs11122391 AﬁG miR-137 18.1 0.52 0
NM_001164547 rs61737326 CﬁT miR-1255a 16.6 0.31 0
EPHB2 NM_004442, NM_017449 rs2229871 CﬁT miR-143-3p 20.3 3.04 0.999
HEPACAM NM_152722 rs3802904 AﬁG miR-1292 29.4 0.86 0
HLA-DRB1 NM_002124 rs9269693 GﬁC miR-17-3p 24.9 0.26 0.017
PCDHA1 NM_018900, NM_031411 rs7701616* AﬁG miR-369-3p 16.9 3.15 1.0
PIK3CG NM_002649 rs140716866 AﬁG miR-140-3p 18.7 1.8 0.027
miR-589-3p 17.1 1.8 0.027
miR-497-3p 18.6 1.8 0.027
RGS7 NM_002924 rs116246787 TﬁC miR-143-3p 17.5 2.94 0.757
SCFD2 NM_152540 rs138867267 GﬁA miR-33a-5p 20.2 8.21 0
miR-33b-5p 18.6 8.21 0
TNIP2 NM_001161527, NM_024309 rs16843312 GﬁA miR-1262 19.2 1.73 0.001
XIRP1 NM_001198621 rs3732383 GﬁA miR-301a-5p 26.2 0.24 0.016
rs75731397 GﬁA miR-185-3p 33.2 7.54 0
Note: MREc-SNP indicates MRE-creating SNPs; DDG means difference in minimum free energy. ‘*’ indicates that this SNP also creates MRE for miR-369-3p across other PCDHA family genes,
including PCDHA2 (NM_018905), PCDHA3 (NM_018906), PCDHA4 (NM_018907), PCDHA5 (NM_018908), PCDHA6 (NM_018909), PCDHA7 (NM_018910), PCDHA8 (NM_018911),
PCDHA9 (NM_014005), PCDHA10 (NM_018901, NM_031860), PCDHA11 (NM_018902), PCDHA12 (NM_01890), PCDHA13 (NM_018904), PCDHAC1 (NM_018898) and PCDHAC2
(NM_018899). GERP, genomic evolutionary rate proﬁling; phastCons, phylogenetic analysis with space/time model for conservation; DISC1, disrupted in schizophrenia 1; EPHB2, EPH receptor B2;
HEPACAM, hepatic and glial cell adhesion molecule; HLA-DRB1, major histocompatibility complex class II, DR beta 1; PCDHA1, protocadherin alpha 1; PIK3CG, phosphoinositide-3-kinase,
catalytic subunit gamma; RGS7, regulator of G-protein signaling 7; SCFD2, sec1 family domain-containing 2; TNIP2, TNFAIP3-interacting protein 2; XIRP1, xin actin-binding repeat-containing 1.
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Table 3 ASD candidate genes associated with mouse phenotypes exhibiting neurobiological deﬁcits
Gene symbol MGI ID Associated mouse phenotypes Associated human disease model
Ntrk3 97385 Homozygotes for targeted mutations
show a range of phenotypes including
postnatal death at 2–21 days, cardiac
defects, reduced numbers of dorsal
root ganglia neurons and germ cells,
abnormal motor coordination and
posture and abnormal sensory
innervation
Plcb1 97613 Homozygotes for a targeted null
mutation exhibit spontaneous seizures
and high mortality around 3 weeks of
age. Mutant males exhibit sperm with
a reduced acrosome reaction rate and
fertilizing capacity in vitro and
decreased fertility in vivo
Alzheimer’s disease, schizophrenia
Prkcb 97596 Mice homozygous for a null allele
exhibit impaired humoral immune
responses, altered proliferative
responses of B cells to various stimuli,
abnormal vascular wound healing
and deﬁcits in contextual and cued
fear conditioning. ENU-induced
mutations lead to impaired T cell-
independent IgM responses
Snrpn 98347 Homozygotes for targeted intragenic
deletions are phenotypically normal.
Deletions that also encompass
neighboring genes on the paternal
chromosome exhibit growth
retardation, hypotonia and high
mortality
Angelman syndrome, Prader-Willi syndrome
Disc1 2447658 Homozygotes for a null allele show
altered anxiety, synaptic depression,
LTP, impulsivity, social investigation,
hyperactivity and prepulse inhibition.
Homozygotes for a spontaneous
allele show altered working memory.
Diﬀerent ENU mutations cause
distinct depression and schizophrenia-
like proﬁles
Schizophrenia, major depressive disorder
Ephb2 99611 Mice homozygous for a null allele
exhibit abnormal axon guidance,
circling, head bobbing and
hyperactivity
Rgs7 1346089 Mice homozygous for a hypomorphic
allele exhibit reduced exploration in a
new environment, impaired glucose
tolerance in males and abnormal rod
b-wave electrophysiology. Mice
homozygous for a knock-out allele
exhibit runting, delayed eye opening
and transient prolonged b-wave
implicit time
Note: Data were compiled from Mouse Genome Informatics (MGI) database. Deﬁcits or changes in neurobiological functions in the mice models
are italicized and underlined. Genes associated with human disease models are highlighted in bold. ENU, N-ethyl-N-nitrosourea; Ntrk3, neuro-
trophic tyrosine kinase receptor type 3; Plcb1, phospholipase C beta 1; Prkcb, protein kinase C beta; Snrpn, small nuclear ribonucleoprotein N;
Disc1, disrupted in schizophrenia 1; Ephb2, Eph receptor B2; Hepacam, hepatocyte cell adhesion molecule; Rgs7, regulator of G protein signaling
7.
Vaishnavi V et al / MicroRNA Binding Site Polymorphisms in Autism 99identiﬁed SNPs may also add to the genetic heterogeneity
besides their role in ASD predisposition and pathogenesis in
at least a subpopulation of individuals. These candidate SNPs
merit future experimental investigations.Discussion
Despite recent advances in genetics and imaging, the neurobi-
ology of ASD remains largely obscure indicating that there is
100 Genomics Proteomics Bioinformatics 12 (2014) 92–104ample space for exploring new hypotheses regarding the etio-
logical basis of the disorder [44]. SNPs are the most common
form of genetic variation in the human genome and are known
to confer risk and heterogeneity to human disease pathogene-
sis, clinical course, and response to treatment [45,46]. Owing to
its polygenic etiology, SNPs in several genes have been associ-
ated with ASD [47]. Apart from the SNPs that occur in pro-
tein-coding regions of the gene, regulatory polymorphisms in
non-coding regions of the genome might also play a role in
driving human phenotypic variation [48,49]. Many autism-
implicated genes are under the post-transcriptional regulation
of miRNAs, and several human genetic studies have provided
some potential connections between miRNA abnormalities
and ASD phenotypes. Using multiplex quantitative PCR,
Abu-Elneel et al. [19] compared the expression of 466 human
miRNAs in postmortem cerebellar cortex tissue samples
obtained from 13 ASD individuals and an equal number of
non-autistic control individuals. Expression of 28 miRNAs
in ASD patients differed signiﬁcantly from that in the non-aut-
ism control set in at least one of the autism samples. In another
study [50], microarray proﬁling identiﬁed 9 miRNAs to be dif-
ferentially expressed in lymphoblastoid cell line samples of
ASD patients as compared to the matched controls. Addition-
ally, a number of miRNA expression proﬁling studies have
examined miRNA dysregulation in lymphoblastoid cell lines
of ASD patients [51,52]. Recently, our group addressed the
biological and functional signiﬁcance of miRNAs residing at
autism-associated copy number variants and their target genes
by using an array of computational tools [53]. Given the
involvement of miRNAs in ASD pathogenesis, characteriza-
tion of SNPs that occur in cis sequences, such as MREs, is
essential for understanding this peculiar mode of miRNA dys-
function. This mode of miRNA dysfunction does not directly
alter miRNA or mRNA abundance, but interferes with their
interaction instead. Of note, the ﬁrst psychiatric disease linked
to genetic variation in the miR-189 MRE of SLITRK1 encod-
ing SLIT and NTRK-like family member 1 was the Tourette’s
syndrome [25]. Moreover, in a recent study, the promoter and
30UTR of NLGN4 (neuroligin 4) in a group of 285 ASD cases
and 384 controls were sequenced and some 30UTR variants
such as rs3810688, rs5916269 and rs140700235 were found
within putative binding sites of miRNAs that might affect
NLGN4 expression [54].
Numerous databases [31,55,56] have cataloged several
thousands of MRE-SNPs, and identiﬁcation of functional
SNPs amid these MRE-SNPs associated with a complex trait
like autism is extremely challenging. We developed a rigorous
computational approach based on the latest knowledge of
miRNA-mediated post-transcriptional gene regulation. Using
this approach, we identiﬁed a panel of high-conﬁdence candi-
date SNPs that may perturb the expression of autism-impli-
cated genes. The MREs predicted to be modulated by SNPs
have a good miRSVR score and total context score indicating
their functional signiﬁcance. The MREs created exclusively by
the variant alleles of SNPs provide a perfect match for the
miRNA seed sequence and favorable hybridization energy,
thus the corresponding genes may be ‘‘over’’ repressed from
translation. The phastCons and GERP values are also pro-
vided to underscore the level of conservation of the SNP loci.
Of further interest is the characteristic MAF of these MRE-
SNPs (Table S2). For example, some SNPs such as
rs28562651 and rs11122391 have a very low MAF in EAscompared to AAs (0.016% in EA vs. 6.77% in AA and
0.15% in EA vs. 24.34% in AA, respectively). The converse
is also true as exempliﬁed by rs1042589 (44.37% in EA vs.
23.84% in AA) and rs3732383 (22.4% in EA vs. 4.72% in
AA). Moreover, certain SNPs like rs148637931, rs112904440,
rs61737326, rs2229871, rs140716866 and rs11624787 were
detectable only in AAs. This demonstrates that some SNPs
are positively selected in one population and under purifying
selection in the other population. The SNPs rs1042589,
rs3802904 and rs9269693 are common (MAF> 5%), while a
few are uncommon (MAF< 5%) and many others are rare
(MAF< 0.5%). Thus a precise estimate of the relative contri-
bution of rare and common variation to ASD risk will require
further research [57].
Not only the genes, the miRNAs known to bind the SNP-
involved MREs identiﬁed in their 30UTR were also previously
known for their association with the pathophysiology of ASD
and other neuronal disorders. For example, the microRNAs
hsa-miR-671-5p, hsa-miR-489, hsa-miR-589-3p, hsa-miR-497-
3p, hsa-miR-33b-5p and hsa-miR-185-3p were reported to
residewithin CNVs associated consistently withASD [53]. Sara-
chana et al. [51] identiﬁed hsa-miR-185 and hsa-miR-194 to be
up regulated in lymphoblastoid cell lines of autistic individuals.
Also, altered levels of hsa-miR-550 and hsa-miR-140 have been
implicated in autism [19]. The miRNAs hsa-miR-137, hsa-miR-
301a, hsa-miR-489 and hsa-miR-497 have been associated with
depression [58]. In addition, all the above mentioned miRNAs
except hsa-miR-33b-5p are expressed in the post-mortem brain
tissue samples of individuals affected by schizophrenia or bipo-
lar disorder [59]. Overall, our results as well as other studies indi-
cate that miRNAs can have great impact on neuronal function
and communication by regulating the expression of their target
genes and the presence of MRE-SNPs adds another layer of
complexity to the genetic architecture of neuropsychiatric disor-
ders such as ASD, schizophrenia, etc.
Our study has carefully considered the essential features
that determine miRNA-mediated gene regulation to better
understand the effect of MRE-SNPs and their association with
ASD. Despite the requirement of a perfect match between
miRNA seed region and MRE [60], it has been shown that
G:U wobble in the seed region is acceptable [61,62]. To
account for this, we admitted G:U wobble in seed pairing while
predicting the miRNA:MRE interactions in RNAhybrid, so
that the variant allele of the SNP that simply leads to G:U
wobbling without any change in the miRNA:MRE pairing
and hybridization energy can be excluded. As the miR-
NA:mRNA duplex is known to contain self-loops and bulge
loops, SNPs in these regions may not have an effect on base
pairing or hybridization energy and hence they were omitted.
For a subset of SNPs, there was ambiguity in the ancestral
allele when cross-checked with NCBI’s dbSNP, and such cases
were also excluded. Wherever discrepancies existed in predic-
tion between miRanda, TargetScan and RNAhybrid, the
results were discarded. Despite these considerations, a few lim-
itations exist. Human neurodevelopment is a complex and pre-
cisely-regulated process, in which nearly 90% of the expressed
genes and a set of miRNAs show differential regulation across
brain regions and/or time [42,63]. Therefore, spatio-temporal
expression of miRNAs and their target genes may confound
the effect of these MRE-SNPs. Further, we have focused only
on MRE-SNPs, leaving behind the smallest fraction of 30UTR
SNPs that affect 30UTR splicing. These SNPs are predicted to
Vaishnavi V et al / MicroRNA Binding Site Polymorphisms in Autism 101mediate loss of MREs, mostly through the gain of acceptor
splice sites resulting in shortened 30UTRs [64]. Similar to
MRE-SNPs, SNPs in miRNA sequence may also perturb miR-
NA binding and subsequent regulation of gene expression, or
they can affect the processing or maturation of the miRNAs,
thus resulting in disease susceptibility [24,65]. Besides RNA–
RNA interactions, RNA binding proteins might play a role
in miRNA target site recognition as well, either via blocking
or facilitating access to the target region [66]. As the list of
miRNA-related SNPs and other regulatory variants keeps
growing, integrative analysis and experimental validation of
their effect on gene expression will be useful for delineating
the complex etiology of autism and for deciphering how the
different etiological factors act in concert to bring about the
various phenotypes. This work points out a unique genetic
mechanism that alters the translation of genes in the autistic
brain and also provides potential candidates for future exper-
imental validation. Our data suggest that MRE-SNPs may
contribute to autism susceptibility, genetic heterogeneity and
phenotypic variability. Therefore, MRE-SNPs hold promise
for a better understanding of ASD with a consequent improve-
ment in the tools for diagnosis and treatment.
Materials and methods
Autism-implicated gene dataset
The genes implicated in autism were retrieved from the Human
GeneModule of the SFARIGene, which serves as a comprehen-
sive, up-to-date reference for all known human genes associated
with ASD [30]. SFARI Gene is a publicly available, curated,
web-based, searchable database built by extracting information
from the studies on molecular genetics and biology of ASD and
can be accessed at http://gene.sfari.org. At the time of this study,
484 genes (Table S3) were listed in the ‘‘Human Gene Module’’
as autism-implicated genes (accessed on April 8, 2013).
Preliminary characterization of MRE-SNPs
The ofﬁcial gene symbols of the autism-implicated genes were
uploaded in text format to MirSNP database [31] to retrieve
the list of MRE-SNPs. The MirSNP database, available at
http://202.38.126.151/hmdd/mirsnp/search/, was developed
by integrating mRNA sequence information from NCBI,
SNPs from dbSNP135 and miRNAs from miRBase 18.0. Mir-
SNP employs miRanda miRNA target prediction algorithm
[34], which incorporates current biological knowledge on tar-
get rules, and an up-to-date compendium of mammalian miR-
NAs. The MRE-SNPs were checked in EVS to obtain
information on their MAFs, phastCons scores and GERP
scores. The EVS [32] is maintained by NHLBI Exome
Sequencing Project and is freely accessible at http://
evs.gs.washington.edu/EVS/ with options for downloading
the datasets. Only the SNPs with a MAF greater than 0.1%
were considered for further analyses.
Identiﬁcation of functional MREs and MREm-SNPs
The SNP-involved MREs predicted by MirSNP’s miRanda
algorithm were subjected to cross-prediction with twoadditional miRNA target site prediction algorithms namely
TargetScanHuman 6.2 [37] and RNAhybrid [38,39]. Target-
Scan prediction criteria is based on strong pairing in the seed
region, thermodynamic stability, number of target sites on
the 30UTR of a given mRNA, sequence context (location of
MRE with regard to stop codon and to the poly A tail or pres-
ence of AU-rich clusters) and accessibility of the target site to
the RISC complex [13,36]. Besides strong/moderate pairing in
the seed region and thermodynamic stability, RNAhybrid
offers the unique possibility of tuning the search parameters
like seed length and the presence of G:U wobble in seed pairing
[38,39]. Therefore, this cross-prediction approach covers the
multiple features shown to be informative for MRE identiﬁca-
tion and thus reduces false positives. In addition, the MREs
were ranked and selected based on their miRanda-miRSVR
score [40] and TargetScan’s total context score [37]. In other
words, only the MREs with a ‘‘good’’ miRSVR score of
<0.1 were considered and whenever this score was unavail-
able, those with a good total context score of 60.1 were
included. Further, the hybridization energy required for the
formation of miRNA:MRE duplex was calculated by submit-
ting the sequence of 30UTR segments containing the MREs
and their respective miRNAs in RNAhybrid. Only the
duplexes with favorable hybridization energy of P15 kcal/
mol were chosen. The SNP induced mismatch in miR-
NA:MRE interaction was then analyzed in RNAhybrid by
replacing the ancestral allele with the derived allele at the
SNP loci of the MRE. The difference in minimum free energy
(MFE) of binding before and after introduction of the SNP
was computed as DDG (kcal/mol) using the following formula:
DDG ¼ ðMFE of miRNA : mRNA duplexancestral alleleÞ
 ðMFE of miRNA : mRNA duplexderived alleleÞ
In case of SNPs that totally disrupt the formation of miR-
NA:MRE duplex, the MFE was set to ‘0’ with respect to the
derived allele.
Identiﬁcation of MREc-SNPs
The list of MREc-SNPs with MAF> 0.1% were veriﬁed in
a step-wise manner as detailed below. Since the MRE is cre-
ated only after the introduction of the variant allele, the ori-
ginal sequence of the 30UTR should be devoid of that
particular MRE. This was conﬁrmed by the combined use
of TargetScan and RNAhybrid. As these MREs do not have
an miRSVR score or a total context score, we veriﬁed their
effect on miRNA binding by checking the sequence of each
created MRE and their respective miRNA for canonical
hybridization features in RNAhybrid. The DDG was calcu-
lated as previously described except that the MFE of the
miRNA:MRE duplex was set to ‘0’ with respect to the
ancestral allele.Shortlisting MRE-SNPs based on tissue-speciﬁc miRNAs
The neurobiological basis of ASD indicates that the implicated
genes mostly function at the synapse and are expressed in the
brain. Likewise, the miRNAs that regulate these genes should
also be expressed in the brain. Previously,Huet al. [41] performed
both Illumina small RNA sequencing and Agilent miRNA
102 Genomics Proteomics Bioinformatics 12 (2014) 92–104microarray to detect the miRNAs expressed in human brain tis-
sue samples that were obtained from the NICHD Brain and Tis-
sueBank forDevelopmentalDisorders.Another recent study [42]
assessed the spatio-temporal expression of miRNAs in the pre-
frontal cortex, hippocampus and cerebellumof 18 normal human
donor brains spanning different developmental timeperiods right
from infancy through adulthood. In order to achieve consistency
and robustness, we utilized the overlapping list of brain expressed
human miRNAs from both studies for shortlisting those SNP-
involved MREs that serve as their binding sites.Mapping aberrant expression of candidate genes with mouse
phenotypes
To elucidate the phenotypic consequences of aberrant gene
expression caused by the candidate MRE-SNPs, we queried
their gene symbols in Mouse Genome Informatics (MGI) data-
base [67] using the Genes and Markers Query Form, and
retrieved the mouse phenotypes related to targeted knock out
or homozygous null mutation of the homologous allele. MGI
is a complete catalog of phenotypic mutations in laboratory
mouse, and curates data using several different ontologies
including theMammalian Phenotype Ontology [68]. The mouse
genotypes that are explicitly used as a model for human diseases
are additionally linked with the records of Online Mendelian
Inheritance in Man (OMIM). Further, the candidate genes
and the miRNAs known to bind the SNP-involved MREs were
checked in the scientiﬁc literature for any relevance to autism.Authors’ contributions
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